Comments
Loading...

Bicycle Therapeutics Analyst Ratings

BCYCNASDAQ
Logo brought to you by Benzinga Data
$9.49
-0.06-0.63%
At close: -
$9.49
0.000.00%
After Hours: 4:00 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$60.00
Lowest Price Target1
$15.00
Consensus Price Target1
$37.13

Bicycle Therapeutics Analyst Ratings and Price Targets | NASDAQ:BCYC | Benzinga

Bicycle Therapeutics PLC has a consensus price target of $37.13 based on the ratings of 17 analysts. The high is $60 issued by Canaccord Genuity on February 21, 2024. The low is $15 issued by Stephens & Co. on January 22, 2025. The 3 most-recent analyst ratings were released by Needham, Citizens Capital Markets, and HC Wainwright & Co. on March 11, 2025, February 26, 2025, and February 26, 2025, respectively. With an average price target of $29.67 between Needham, Citizens Capital Markets, and HC Wainwright & Co., there's an implied 212.61% upside for Bicycle Therapeutics PLC from these most-recent analyst ratings.

Analyst Trends and Forecast
1
1
Dec 24
2
1
Jan
2
Feb
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Needham
Citizens Capital Markets
HC Wainwright & Co.
Stephens & Co.
JMP Securities

1calculated from analyst ratings

Analyst Ratings for Bicycle Therapeutics

Buy NowGet Alert
03/11/2025Buy Now216.12%Needham
Ami Fadia62%
$30 → $30ReiteratesBuy → BuyGet Alert
02/26/2025Buy Now173.97%Citizens Capital Markets
Reni Benjamin46%
$26 → $26ReiteratesMarket Outperform → Market OutperformGet Alert
02/26/2025Buy Now247.73%HC Wainwright & Co.
Swayampakula Ramakanth50%
$33 → $33ReiteratesBuy → BuyGet Alert
02/26/2025Buy Now216.12%Needham
Ami Fadia62%
$30 → $30ReiteratesBuy → BuyGet Alert
01/22/2025Buy Now58.06%Stephens & Co.
Sudan Loganathan31%
$15 → $15ReiteratesEqual-Weight → Equal-WeightGet Alert
01/13/2025Buy Now247.73%HC Wainwright & Co.
Swayampakula Ramakanth50%
$33 → $33ReiteratesBuy → BuyGet Alert
01/13/2025Buy Now237.2%Needham
Ami Fadia62%
$32 → $32ReiteratesBuy → BuyGet Alert
12/18/2024Buy Now173.97%JMP Securities
Reni Benjamin46%
$32 → $26MaintainsMarket OutperformGet Alert
12/16/2024Buy Now247.73%HC Wainwright & Co.
Swayampakula Ramakanth50%
$55 → $33MaintainsBuyGet Alert
12/13/2024Buy Now79.14%B. Riley Securities
Kalpit Patel40%
$28 → $17MaintainsNeutralGet Alert
11/08/2024Buy Now163.44%Stephens & Co.
Sudan Loganathan31%
→ $25Initiates → Equal-WeightGet Alert
11/01/2024Buy Now268.81%RBC Capital
Gregory Renza49%
$35 → $35ReiteratesOutperform → OutperformGet Alert
11/01/2024Buy Now479.56%HC Wainwright & Co.
Swayampakula Ramakanth50%
$55 → $55ReiteratesBuy → BuyGet Alert
10/31/2024Buy Now300.42%Needham
Ami Fadia62%
$38 → $38ReiteratesBuy → BuyGet Alert
10/24/2024Buy Now479.56%HC Wainwright & Co.
Swayampakula Ramakanth50%
$55 → $55ReiteratesBuy → BuyGet Alert
10/24/2024Buy Now300.42%Needham
Ami Fadia62%
$38 → $38ReiteratesBuy → BuyGet Alert
09/16/2024Buy Now237.2%JMP Securities
Reni Benjamin46%
$32 → $32ReiteratesMarket Outperform → Market OutperformGet Alert
09/16/2024Buy Now479.56%HC Wainwright & Co.
Swayampakula Ramakanth50%
$55 → $55ReiteratesBuy → BuyGet Alert
09/16/2024Buy Now300.42%Needham
Ami Fadia62%
$38 → $38ReiteratesBuy → BuyGet Alert
09/09/2024Buy Now300.42%Needham
Ami Fadia62%
$38 → $38ReiteratesBuy → BuyGet Alert
09/09/2024Buy NowCantor Fitzgerald
Li Watsek41%
Reiterates → OverweightGet Alert
09/06/2024Buy Now268.81%RBC Capital
Gregory Renza49%
→ $35Initiates → OutperformGet Alert
08/07/2024Buy Now479.56%HC Wainwright & Co.
Swayampakula Ramakanth50%
$55 → $55ReiteratesBuy → BuyGet Alert
08/07/2024Buy Now405.8%Oppenheimer
Jay Olson62%
$48 → $48MaintainsOutperformGet Alert
08/07/2024Buy Now300.42%Needham
Ami Fadia62%
$38 → $38ReiteratesBuy → BuyGet Alert
08/07/2024Buy Now195.05%B. Riley Securities
Kalpit Patel40%
$33 → $28DowngradeBuy → NeutralGet Alert
05/03/2024Buy Now479.56%HC Wainwright & Co.
Swayampakula Ramakanth50%
$55 → $55ReiteratesBuy → BuyGet Alert
04/10/2024Buy Now353.11%Needham
Ami Fadia62%
$43 → $43ReiteratesBuy → BuyGet Alert
02/21/2024Buy Now353.11%Needham
Ami Fadia62%
$43 → $43ReiteratesBuy → BuyGet Alert
02/21/2024Buy Now532.24%Canaccord Genuity
Bill Maughan19%
→ $60ReiteratesBuy → BuyGet Alert
02/21/2024Buy Now479.56%HC Wainwright & Co.
Swayampakula Ramakanth50%
$57 → $55MaintainsBuyGet Alert
12/20/2023Buy Now237.2%JMP Securities
Reni Benjamin46%
$44 → $32MaintainsMarket OutperformGet Alert
12/15/2023Buy Now353.11%Needham
Ami Fadia62%
$46 → $43MaintainsBuyGet Alert
11/08/2023Buy Now584.93%Cantor Fitzgerald
Li Watsek41%
→ $65ReiteratesOverweight → OverweightGet Alert
11/03/2023Buy Now321.5%Morgan Stanley
Jeffrey Hung56%
$42 → $40MaintainsEqual-WeightGet Alert
09/12/2023Buy Now247.73%B. Riley Securities
Kalpit Patel40%
→ $33UpgradeNeutral → BuyGet Alert
09/12/2023Buy Now584.93%Cantor Fitzgerald
Li Watsek41%
→ $65ReiteratesOverweight → OverweightGet Alert
09/12/2023Buy Now363.65%JMP Securities
Reni Benjamin46%
→ $44ReiteratesMarket Outperform → Market OutperformGet Alert
09/12/2023Buy Now384.72%Needham
Ami Fadia62%
→ $46ReiteratesBuy → BuyGet Alert
09/11/2023Buy Now247.73%B. Riley Securities
Kalpit Patel40%
$33 → $33UpgradeNeutral → BuyGet Alert
09/07/2023Buy Now584.93%Cantor Fitzgerald
Li Watsek41%
→ $65ReiteratesOverweight → OverweightGet Alert
08/04/2023Buy Now342.57%Morgan Stanley
Jeffrey Hung56%
$42 → $42ReiteratesEqual-Weight → Equal-WeightGet Alert
08/04/2023Buy Now363.65%JMP Securities
Reni Benjamin46%
$46 → $44MaintainsOutperformGet Alert
08/04/2023Buy Now500.63%HC Wainwright & Co.
Swayampakula Ramakanth50%
→ $57ReiteratesBuy → BuyGet Alert
08/04/2023Buy Now384.72%Needham
Ami Fadia62%
$48 → $46MaintainsBuyGet Alert
08/03/2023Buy Now426.87%EF Hutton
Tony Butler43%
→ $50Reiterates → BuyGet Alert
05/11/2023Buy Now384.72%JMP Securities
Reni Benjamin46%
$46 → $46ReiteratesMarket Outperform → Market OutperformGet Alert
05/08/2023Buy Now479.56%Oppenheimer
Jay Olson62%
→ $55Reiterates → OutperformGet Alert
05/05/2023Buy Now384.72%JMP Securities
Reni Benjamin46%
→ $46Reiterates → Market OutperformGet Alert
05/05/2023Buy Now500.63%HC Wainwright & Co.
Swayampakula Ramakanth50%
→ $57Reiterates → BuyGet Alert
05/05/2023Buy Now574.39%Needham
Ami Fadia62%
$67 → $64MaintainsBuyGet Alert
04/19/2023Buy Now479.56%EF Hutton
Tony Butler43%
→ $55Reiterates → BuyGet Alert
04/18/2023Buy Now384.72%JMP Securities
Reni Benjamin46%
→ $46Reiterates → Market OutperformGet Alert
03/01/2023Buy Now500.63%HC Wainwright & Co.
Swayampakula Ramakanth50%
→ $57Reiterates → BuyGet Alert
03/01/2023Buy Now606.01%Needham
Ami Fadia62%
$72 → $67MaintainsBuyGet Alert
02/28/2023Buy Now479.56%EF Hutton
Tony Butler43%
→ $55Reiterates → BuyGet Alert
02/27/2023Buy Now679.77%Cantor Fitzgerald
Li Watsek41%
→ $74Reiterates → OverweightGet Alert
02/15/2023Buy Now479.56%EF Hutton
Tony Butler43%
→ $55Reiterates → BuyGet Alert
02/15/2023Buy Now500.63%HC Wainwright & Co.
Swayampakula Ramakanth50%
→ $57Reiterates → BuyGet Alert
02/15/2023Buy Now658.69%Needham
Ami Fadia62%
→ $72Reiterates → BuyGet Alert
01/05/2023Buy Now479.56%EF Hutton
Tony Butler43%
→ $55Initiates → BuyGet Alert
11/09/2022Buy Now384.72%JMP Securities
Reni Benjamin46%
$70 → $46MaintainsMarket OutperformGet Alert
09/12/2022Buy Now374.18%Morgan Stanley
Jeffrey Hung56%
$60 → $45MaintainsEqual-WeightGet Alert
08/31/2022Buy NowCowen & Co.
Tara Bancroft66%
Initiates → OutperformGet Alert
08/22/2022Buy Now426.87%SVB Leerink
Jonathan Chang38%
$48 → $50MaintainsOutperformGet Alert
08/05/2022Buy Now405.8%SVB Leerink
Jonathan Chang38%
$69 → $48MaintainsOutperformGet Alert
08/05/2022Buy Now500.63%HC Wainwright & Co.
Swayampakula Ramakanth50%
$65 → $57MaintainsBuyGet Alert
07/28/2022Buy Now216.12%Barclays
Peter Lawson42%
→ $30Initiates → OverweightGet Alert
07/06/2022Buy Now532.24%Canaccord Genuity
William Maughan71%
→ $60Assumes → BuyGet Alert
05/23/2022Buy Now289.88%Piper Sandler
Edward Tenthoff52%
$76 → $37MaintainsOverweightGet Alert
05/06/2022Buy Now627.08%SVB Leerink
Jonathan Chang38%
$70 → $69MaintainsOutperformGet Alert
04/13/2022Buy Now247.73%B. Riley Securities
Kalpit Patel40%
$62 → $33DowngradeBuy → NeutralGet Alert
04/12/2022Buy Now690.31%Needham
Ami Fadia62%
$85 → $75MaintainsBuyGet Alert

FAQ

Q

What is the target price for Bicycle Therapeutics (BCYC) stock?

A

The latest price target for Bicycle Therapeutics (NASDAQ:BCYC) was reported by Needham on March 11, 2025. The analyst firm set a price target for $30.00 expecting BCYC to rise to within 12 months (a possible 216.12% upside). 28 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Bicycle Therapeutics (BCYC)?

A

The latest analyst rating for Bicycle Therapeutics (NASDAQ:BCYC) was provided by Needham, and Bicycle Therapeutics reiterated their buy rating.

Q

When was the last upgrade for Bicycle Therapeutics (BCYC)?

A

The last upgrade for Bicycle Therapeutics PLC happened on September 12, 2023 when B. Riley Securities raised their price target to $33. B. Riley Securities previously had a neutral for Bicycle Therapeutics PLC.

Q

When was the last downgrade for Bicycle Therapeutics (BCYC)?

A

The last downgrade for Bicycle Therapeutics PLC happened on August 7, 2024 when B. Riley Securities changed their price target from $33 to $28 for Bicycle Therapeutics PLC.

Q

When is the next analyst rating going to be posted or updated for Bicycle Therapeutics (BCYC)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bicycle Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bicycle Therapeutics was filed on March 11, 2025 so you should expect the next rating to be made available sometime around March 11, 2026.

Q

Is the Analyst Rating Bicycle Therapeutics (BCYC) correct?

A

While ratings are subjective and will change, the latest Bicycle Therapeutics (BCYC) rating was a reiterated with a price target of $30.00 to $30.00. The current price Bicycle Therapeutics (BCYC) is trading at is $9.49, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch